A Cure In Sight, in partnership with the UCSF Ocular Oncology Center and NORD, Launches Landmark Ocular Melanoma Natural History Study

Source: National Organization for rare Disorders, September 2020

Cleveland, OH, September 28, 2020—A Cure in Sight and the National Organization for Rare Disorders have launched an innovative study to research ocular melanoma, a disease that can cause blindness, loss of the eye and even death from spread to other organs.

The new study, INSIGHT: A Global Ocular Melanoma Patient Registry, creates a platform for patients around the world to share information about ocular melanoma.

Its purpose is to build an international resource to be used by scientists in future research. A Cure in Sight™ (ACIS) and the University of California, San Francisco Beckman Vision Center (UCSF) have spent considerable time working to research the best possible way to capture valuable information that will assist in understanding and treating the rare disease that is ocular melanoma.

READ THE ORIGINAL FULL ARTICLE